Resources Investment Advisors, Llc. Galectin Therapeutics Inc Transaction History

Resources Investment Advisors, Llc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$3.86 - $6.02 $15,440 - $24,080	-4,000 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$3.68 - $6.93 $1,840 - $3,465	500 Added 14.29%	4,000 $24,000
Q2 2018 Aug 15, 2018	BUY	$3.16 - $9.16 $11,060 - $32,060	3,500 New	3,500 $22,000

9.65M

1.16M

1.98M

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $54.7M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Resources Investment Advisors, Llc. with notifications on news.